AAAAAA

   
Results: 1-9 |
Results: 9
ASSESSMENT OF SALIVARY FLOW AND FUNCTIONAL IMPROVEMENT IN CANCER-PATIENTS WITH ORAL PILOCARPINE AS TREATMENT FOR ANALGESIA-INDUCED XEROSTOMIA
Authors: CHAMBERS MS TOOTH BB KEENE HJ MARTIN CG PAYNE R MUSCOPLAT CC GALLAGHER SC HANNA JK KING GE
Citation: Ms. Chambers et al., ASSESSMENT OF SALIVARY FLOW AND FUNCTIONAL IMPROVEMENT IN CANCER-PATIENTS WITH ORAL PILOCARPINE AS TREATMENT FOR ANALGESIA-INDUCED XEROSTOMIA, Journal of dental research, 77, 1998, pp. 1478-1478
SEQUENCE-ALIGNMENT MODELING AND MOLECULAR DOCKING STUDIES OF THE EPOXYGENASE COMPONENT OF ALKENE MONOOXYGENASE FROM NOCARDIA-CORALLINA-B-276
Authors: GALLAGHER SC GEORGE A DALTON H
Citation: Sc. Gallagher et al., SEQUENCE-ALIGNMENT MODELING AND MOLECULAR DOCKING STUDIES OF THE EPOXYGENASE COMPONENT OF ALKENE MONOOXYGENASE FROM NOCARDIA-CORALLINA-B-276, European journal of biochemistry, 254(3), 1998, pp. 480-489
MUTANS STREPTOCOCCI AND SALIVARY FLOW-RATES IN CANCER-PATIENTS ATTENDING A PAIN CLINIC
Authors: CHAMBERS MS TOTH BB PAYNE R KING GE MUSCOPLAT CC SHROTRIYA RC GALLAGHER SC HANNA JK KEENE HJ
Citation: Ms. Chambers et al., MUTANS STREPTOCOCCI AND SALIVARY FLOW-RATES IN CANCER-PATIENTS ATTENDING A PAIN CLINIC, Journal of dental research, 76, 1997, pp. 2755-2755
ALKENE MONOOXYGENASE FROM NOCARDIA-CORALLINA B-276 IS A MEMBER OF THECLASS OF DINUCLEAR IRON PROTEINS CAPABLE OF STEREOSPECIFIC EPOXYGENATION REACTIONS
Authors: GALLAGHER SC CAMMACK R DALTON H
Citation: Sc. Gallagher et al., ALKENE MONOOXYGENASE FROM NOCARDIA-CORALLINA B-276 IS A MEMBER OF THECLASS OF DINUCLEAR IRON PROTEINS CAPABLE OF STEREOSPECIFIC EPOXYGENATION REACTIONS, European journal of biochemistry, 247(2), 1997, pp. 635-641
PHARMACOKINETIC PROFILE OF PILOCARPINE HYDROCHLORIDE IN SUBJECTS WITHIMPAIRED HEPATIC-FUNCTION
Authors: GARG DC LASSETER KC SHROTRIYA RC SHAMBLEN EC SHAMBLEN S HOFF JV GALLAGHER SC
Citation: Dc. Garg et al., PHARMACOKINETIC PROFILE OF PILOCARPINE HYDROCHLORIDE IN SUBJECTS WITHIMPAIRED HEPATIC-FUNCTION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 48-48
ORAL PILOCARPINE FOR RADIATION-INDUCED XEROSTOMIA - INTEGRATED EFFICACY AND SAFETY RESULTS FROM 2 PROSPECTIVE RANDOMIZED CLINICAL-TRIALS
Authors: RIEKE JW HAFERMANN MD JOHNSON JT LEVEQUE FG IWAMOTO R STEIGER BW MUSCOPLAT C GALLAGHER SC
Citation: Jw. Rieke et al., ORAL PILOCARPINE FOR RADIATION-INDUCED XEROSTOMIA - INTEGRATED EFFICACY AND SAFETY RESULTS FROM 2 PROSPECTIVE RANDOMIZED CLINICAL-TRIALS, International journal of radiation oncology, biology, physics, 31(3), 1995, pp. 661-669
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-TITRATION STUDY OF ORAL PILOCARPINE FOR TREATMENT OF RADIATION-INDUCED XEROSTOMIA IN HEAD AND NECK-CANCER PATIENTS
Authors: LEVEQUE FG MONTGOMERY M POTTER D ZIMMER MB RIEKE JW STEIGER BW GALLAGHER SC MUSCOPLAT CC
Citation: Fg. Leveque et al., A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-TITRATION STUDY OF ORAL PILOCARPINE FOR TREATMENT OF RADIATION-INDUCED XEROSTOMIA IN HEAD AND NECK-CANCER PATIENTS, Journal of clinical oncology, 11(6), 1993, pp. 1124-1131
ORAL PILOCARPINE HCI (SALAGEN(TM)) FOR RADIATION-INDUCED XEROSTOMIA -FINAL EFFICACY AND SAFETY RESULTS OF PROSPECTIVE, RANDOMIZED PLACEBO-CONTROLLED TRIALS
Authors: RIEKE JW HAFERMANN MD LEVEQUE F IWAMOTO R GALLAGHER SC
Citation: Jw. Rieke et al., ORAL PILOCARPINE HCI (SALAGEN(TM)) FOR RADIATION-INDUCED XEROSTOMIA -FINAL EFFICACY AND SAFETY RESULTS OF PROSPECTIVE, RANDOMIZED PLACEBO-CONTROLLED TRIALS, International journal of radiation oncology, biology, physics, 27, 1993, pp. 175-175
ORAL PILOCARPINE FOR POSTIRRADIATION XEROSTOMIA IN PATIENTS WITH HEADAND NECK-CANCER
Authors: JOHNSON JT FERRETTI GA NETHERY WJ VALDEZ IH FOX PC NG D MUSCOPLAT CC GALLAGHER SC
Citation: Jt. Johnson et al., ORAL PILOCARPINE FOR POSTIRRADIATION XEROSTOMIA IN PATIENTS WITH HEADAND NECK-CANCER, The New England journal of medicine, 329(6), 1993, pp. 390-395
Risultati: 1-9 |